Andrology · KIMS Secunderabad
Premature Ejaculation — Understanding and Treating the Most Common Male Sexual Dysfunction
Premature ejaculation (PE) is the most common male sexual dysfunction — affecting an estimated 20 to 30% of men across all age groups. It is defined by the International Society for Sexual Medicine (ISSM) as ejaculation that always or nearly always occurs prior to or within approximately 1 minute of vaginal penetration (lifelong PE), or a clinically significant reduction in ejaculatory latency time (often to 3 minutes or less) — in both cases causing distress, bother, or interpersonal difficulty. The 1-minute threshold applies to lifelong PE; the key clinical element for acquired PE is the significant reduction from the previous ejaculatory latency, combined with the distress it causes.
PE is significantly under-diagnosed and under-treated in India. The combination of cultural stigma, embarrassment, and the misconception that PE is a psychological weakness (rather than a neurobiological condition with an effective pharmacological treatment) prevents most men with PE from seeking help. At KIMS, the andrology team evaluates PE clinically, distinguishes the underlying mechanism (neurobiological vs psychological vs secondary to erectile dysfunction), and offers the full range of evidence-based treatments — behavioural, pharmacological, and combined.
Types of premature ejaculation
Lifelong (primary) PE
Present since the first sexual experience. Characterised by consistently short ejaculatory latency (IELT — intravaginal ejaculatory latency time — below 1 to 2 minutes) in virtually all sexual encounters, with all partners. Neurobiological in origin — studies show that men with lifelong PE have a genetically determined hypersensitivity of the ejaculatory reflex arc (faster serotonin reuptake in penile sensory pathways). Highly responsive to pharmacological treatment (dapoxetine, SSRIs).
Acquired (secondary) PE
Develops after a period of normal ejaculatory control. Associated with erectile dysfunction (the most common cause — men with ED who are anxious about losing their erection may rush to ejaculate before losing tumescence), prostatitis, thyroid dysfunction (hyperthyroidism), relationship problems, or psychological factors. Treating the underlying condition (ED management, prostatitis treatment, thyroid correction) often resolves or significantly improves the PE.
Natural variable PE and subjective PE
Natural variable PE: occasional premature ejaculation in a man who normally has adequate ejaculatory control — normal variation, not a disorder. Subjective PE: the patient perceives his ejaculatory latency as too short, but objective measurement shows normal or above-normal IELT — typically driven by unrealistic expectations or relationship anxiety. These are not disorders requiring pharmacological treatment — psychosexual counselling addresses expectations and anxiety.
Diagnosis at KIMS
Detailed sexual history — IELT (estimated time from penetration to ejaculation), frequency of PE (always vs sometimes), partner-specific vs universal, lifelong vs acquired, associated erectile dysfunction, condom use, masturbation IELT (often longer — the difference between partnered and masturbation IELT suggests psychogenic contribution).
PEDT (Premature Ejaculation Diagnostic Tool) — a validated 5-question self-report questionnaire that quantifies PE severity and distinguishes PE from normal variation.
Assessment for concurrent ED — men with PE and ED require treatment of the ED first. SSRIs and dapoxetine do not help PE secondary to ED; the ED must be controlled (with PDE5 inhibitors) before PE treatment is effective.
Thyroid function tests — hyperthyroidism (elevated T4, suppressed TSH) is associated with acquired PE. Thyroid correction resolves the PE in these patients.
Urinalysis and PSA — to exclude prostatitis as a contributing factor to acquired PE.
Pharmacological — the most effective treatment for lifelong PE
Dapoxetine (Priligy)
The only licensed on-demand drug for PE. A short-acting selective serotonin reuptake inhibitor (SSRI) specifically designed for on-demand use for PE. Taken 1 to 3 hours before sexual activity. Increases ejaculatory latency 2 to 3 times above baseline in clinical trials (IELT from below 1 minute to above 2 to 3 minutes in the majority of patients). Adverse effects: nausea, dizziness, headache — typically mild and diminish with continued use. Available in India. Contraindicated with monoamine oxidase inhibitors.
Daily SSRI therapy (off-label)
For lifelong PE in men who prefer daily dosing. Paroxetine 10 to 40mg daily, sertraline 50 to 200mg daily, or fluoxetine 20 to 40mg daily — all significantly delay ejaculation through central serotonergic mechanisms. Take 1 to 2 weeks to reach full effect. Ejaculatory delay persists with daily use. Side effects include reduced libido and delayed orgasm in some patients — monitored and dose-adjusted. Paroxetine is the most effective SSRI for PE by meta-analysis (3 to 8 fold IELT increase).
Topical anaesthetics
Lidocaine-prilocaine cream or spray applied to the glans 15 to 20 minutes before intercourse and wiped off before penetration. Reduces penile sensitivity and delays ejaculation. Effective — IELT increases 4 to 6 fold in some studies. Risk of penile anaesthesia and partner vaginal numbness (if not wiped off before penetration, the anaesthetic transfers to the vagina). EMLA cream or Stud 100 spray — available in India.
Behavioural therapy — for psychogenic and acquired PE
Stop-start technique (Semans technique)
Masturbation stimulation continues until ejaculation is imminent (just before the point of ejaculatory inevitability — the 'pre-ejaculatory plateau'), then all stimulation stops until the sensation subsides, then stimulation restarts. The cycle is repeated 3 to 4 times before allowing ejaculation. Trains the man to recognise and control the ejaculatory threshold. Effective when practised consistently — success rates 60 to 70% initially, but often require combination with pharmacotherapy for sustained benefit.
Squeeze technique (Masters and Johnson)
At the point of ejaculatory inevitability, the partner applies firm pressure to the glans (just below the coronal rim) for 10 to 20 seconds — the squeeze inhibits the ejaculatory reflex. As with stop-start, repeated over several sessions to train ejaculatory control.
Psychosexual counselling
For PE with significant relationship, anxiety, or performance components. Combined pharmacological and psychological therapy achieves better long-term outcomes than either alone in acquired PE with a psychogenic component.
Most men with lifelong PE see dramatic improvement with dapoxetine — taken on demand before sexual activity, it is the simplest, most effective first-line treatment. Men who do not wish to use on-demand medication, or who prefer spontaneity, achieve equivalent results with a daily low-dose SSRI. A trial of 3 to 6 months with behavioural techniques combined with pharmacotherapy gives the best long-term outcomes. A confidential consultation with Dr. Neil Trivedi at KIMS sets out all options.
Book a Confidential Premature Ejaculation Consultation at KIMS. Call 040-4488-5000
Frequently Asked Questions — Premature Ejaculation
Lifelong (primary) PE — present since first sexual experience — has a strong neurobiological basis: men with lifelong PE have a genetically determined hypersensitivity of the ejaculatory reflex and faster central serotonin reuptake than men without PE. This is why pharmacological treatment (SSRIs, dapoxetine) is highly effective for lifelong PE — the drugs correct the neurobiological deficit. Acquired PE — developing after a period of normal function — has a higher proportion of psychological and situational factors (anxiety, relationship problems, concurrent ED). The practical answer: most PE has both neurobiological and psychological components — the best treatment addresses both.
Studies measuring IELT (intravaginal ejaculatory latency time — the time from penetration to ejaculation) in the general population show a median of approximately 5 to 6 minutes, with a range from 1 to 45 minutes. IELT below 1 minute consistently is the threshold defining lifelong PE. The most important clinical element, however, is not the absolute time but the personal and relational distress it causes — a man who ejaculates in 2 minutes without distress and with a satisfied partner does not have PE as a clinical condition requiring treatment. A man who ejaculates in 5 minutes but perceives this as premature and is distressed may have subjective PE and benefit from psychosexual counselling to address unrealistic expectations.
Dapoxetine is specifically designed and licensed as an on-demand medication — taken 1 to 3 hours before anticipated sexual activity. It has a short half-life (approximately 1.5 hours) specifically chosen to allow on-demand dosing without the continuous systemic SSRI effects of daily medications. Daily dapoxetine is not recommended — its rapid onset and short half-life make it pharmacologically unsuitable for daily dosing, and the cumulative exposure would increase side effects without additional benefit. For men who prefer daily dosing, daily low-dose paroxetine, sertraline, or fluoxetine are the appropriate alternatives.
Premature ejaculation in the context of vaginal intercourse does not cause male infertility — ejaculation within the vagina, however early, deposits sperm at the cervical os where they can progress to the fallopian tubes for fertilisation. PE is a sexual satisfaction problem, not a fertility problem. However, if PE is so severe that ejaculation occurs before penetration is achieved (ejaculation during foreplay or at the moment of penetration without intromission), sperm may not be deposited intravaginally and conception may be impaired. This extreme presentation is managed by pharmacological treatment of the PE combined with timed intercourse during the fertile period.
KIMS Secunderabad — Dr. Neil Narendra Trivedi (MCh Urology KEM Mumbai, Member SIU, andrologist), PEDT validated assessment, thyroid and testosterone workup, concurrent ED management with PDE5 inhibitors, dapoxetine and daily SSRI prescribing, stop-start and squeeze technique teaching, combined psychosexual counselling referral. Confidential consultation. Call 040-4488-5000.